René Hurlemann, M.Sc., M.D., Ph.D.
Rene Hurlemann completed his M.D. at the University of Bonn, Germany, in 2001, with a thesis on the timing of intracranial memory-related ERPs in temporal lobe epilepsy. Later, he focused on stress-induced emotion-memory interactions and received his M.Sc. (2006) and Ph.D. (2007) from Maastricht University. Since completing his residency in 2008, he has served as senior physician for the Department of Psychiatry at the University of Bonn and carried on full-time clinical responsibilities running inpatient and outpatient Psychiatry clinics as well as 24/7 emergency call and resident teaching duties. In 2013, he was appointed to head the Medical Psychology Division at the University of Bonn. Since 2015, he has served as Deputy Chair of the Department of Psychiatry. As clinician scientist, he is committed to research in the field of psychiatric neuroscience, with a methodological emphasis on pharmacological fMRI and connectivity-guided TMS. He is principle investigator of the “Neuromodulation of Emotion (NEMO)“ research group, for which he had obtained a 1.4 million Euro starting grant by the Ministry of Innovation, Science, Research, and Technology of the German State of North-Rhine Westfalia (MIWFT) in 2010. His current research is focused on developing cutting-edge experimental therapies along three research trajectories: (i) Oxytocin neuroscience, (ii) brain stimulation for depression, and (iii) schizophrenia early recognition and intervention. He has won several awards and stipends including the 2008 Gerd-Huber Award for PET studies in prodromal psychosis and the 2013 Helen C. Levitt Endowed Annual Visiting Professorship at the University of Iowa Carver College of Medicine. Furthermore, he is Visiting Associate in Psychology at the California Institute of Technology (Caltech), where he studies the causes and consequences of human amygdala dysfunction. In 2010, he was named Director of the Master in Affective Neuroscience joint degree program from the Universities of Maastricht & Florence. Currently, he serves as ad-hoc referee for >15 international public funding agencies and >70 journals, and has become (associate) member of >10 professional societies including the American College of Neuropsychopharmacology (ACNP), the European College of Neuropsychopharmacology (ECNP), the Society for Neuroscience (SfN), and the Society of Biological Psychiatry (SoBP). Due to his interest in promoting precision medicine in Psychiatry, he has joined several (editorial) boards including the WPA section on Personalized Medicine in Psychiatry, Personalized Medicine in Psychiatry (Elsevier) and Der Nervenarzt (Springer Nature). René Hurlemann is certified in operationalized psychodynamic diagnostics (OPD-2), consultation & liaison psychiatry (DGPPN) and non-invasive brain stimulation (NIBS) techniques (DGHP), and has been trained in innovative teaching methods and hospital management.